IVIg Proves Effective for Dermatomyositis in Phase 3 Trial
Prior to this trial, intravenous immune globulin had not been fully studied for the treatment of dermatomyositis.
Source: medscape.com
Total Improvement Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Total Improvement Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Total Improvement Score Today - Breaking & Trending Today
IV Immune Globulin Bests Placebo for Dermatomyositis
WEDNESDAY, Oct. 5, 2022 (HealthDay News) -- Significantly more adults with dermatomyositis receiving intravenous immune globulin (IVIG) versus placebo have a response of at least minimal improvement, according to a
Source: keysnews.com
Octagam 10% Approved for Adult Dermatomyositis
Octagam 10% Approved for Adult Dermatomyositis Credit: Octapharma. The Food and Drug Administration (FDA) has approved Octagam ® 10% (immune globulin intravenous [human]) for the treatment of adult dermatomyositis, a rare immune-mediated inflammatory disease. The approval was based on data from the prospective, double-blind, randomized, placebo-controlled phase 3 ProDERM study (ClinicalTrials.gov Identifier: NCT02728752), which evaluated the efficacy and safety of Octagam 10% in 95 adults with dermatomyositis. Patients were randomly assigned to receive either Octagam ...
Source: empr.com